Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2020, 8(9), 257-261
DOI: 10.12691/AJMCR-8-9-1
Case Study

Employing Amplatzer Occluder® in Cardiac Free Wall Rupture Repair: A Scoping Study

Pramod Theetha Kariyanna1, Ashkan Tadayoni1, Amog Jayarangaiah2, Sudhanva Hegde1, Apoorva Jayaranagaiah3, Moro O. Salifu1 and Isabel M. McFarlane1,

1Department of Internal Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY 11203, U.S.A.

2Trinity School of Medicine, 925 Woodstock Road, Roswell, GA 30075, U.S.A.

3Department of Internal Medicine, Albert Einstein College of medicine/ Jacobi Medical Center, Bronx, N.Y., U.S.A.

Pub. Date: May 22, 2020

Cite this paper

Pramod Theetha Kariyanna, Ashkan Tadayoni, Amog Jayarangaiah, Sudhanva Hegde, Apoorva Jayaranagaiah, Moro O. Salifu and Isabel M. McFarlane. Employing Amplatzer Occluder® in Cardiac Free Wall Rupture Repair: A Scoping Study. American Journal of Medical Case Reports. 2020; 8(9):257-261. doi: 10.12691/AJMCR-8-9-1

Abstract

Cardiac free wall rupture (CFWR) is an uncommon complication of myocardial infarction, cardiac-based procedures, and blunt chest trauma. Cardiac tamponade and shock which occurs as a result of CFWR results in a high mortality rate. Despite the high mortality rate, there is a window of opportunity for intervention in selected patients with acute or subacute free wall rupture. Hence, prompt diagnosis and intervention are key to prevent cardiac tamponade and death. Even though emergency surgical repair is the standard treatment for the CWFR, the catheter-based procedure has provided an alternative treatment option, especially, in the high-risk surgical patients. For instance, Amplatzer occluder® (AO), a device which is used in repairing congenital septal wall defect, is being used as an alternative method of treatment in CFWR. In this systemic review, we assessed the 19 cases of CFWR occurring after invasive cardiac procedures who underwent repair with the utilization of AO®. The study shows that the successful rate of percutaneous closure of CFWR was 84.3% (16/19) with a mortality rate of 15.7% (3/19) in this cohort. Therefore, the in-hospital mortality rate of CFWR closure is comparable with the average in-house mortality rate of emergency surgical repair which is 14%. Furthermore, we found that AO® placement technique has a lower mortality rate compared to the other less-invasive methods such as percutaneous intrapericardial fibrin-glue injection which has a mortality rate of 25%. In conclusion, employing AO® in CFWR repair not only serves as the treatment of choice in the high-risk surgical candidates but could also be applied as an alternative method in the general population. However, further studies are required to assess the outcome and mortality rate of using AO® in CFWR to provide us with a more consistent and accurate data.

Keywords

Amplatzer occluder, Cardiac free wall rupture, acute myocardial complication, catheter-based procedure, surgical repair mortality

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Figueras J, Cortadellas J, Soler-Soler J. Left ventricular free wall rupture: clinical presentation and management. Heart. 2000; 83(5): 499-504.
 
[2]  Dar T, Yarlagadda B, Gunasekaran P, Lakkireddy D, Wiley MA. Successful Percutaneous Closure of Traumatic Right Ventricular Free Wall Rupture Using Amplatzer Vascular Plug Devices. J Atr Fibrillation. 2018; 11(2): 2095.
 
[3]  McMullan MH, Maples MD, Kilgore Jr TL, Hindman SH. Surgical experience with left ventricular free wall rupture. The Annals of thoracic surgery. 2001; 71(6): 1894-9.
 
[4]  Vignati G, Bruschi G, Mauri L, Annoni G, Frigerio M, Martinelli L, et al. Percutaneous device closure of iatrogenic left ventricular wall pseudoaneurysm. The Annals of thoracic surgery. 2009; 88(4): e31-e3.
 
[5]  Shiyovich A, Nesher L. Contained left ventricular free wall rupture following myocardial infarction. Case Rep Crit Care. 2012; 2012.
 
[6]  Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Journal of the American College of Cardiology. 2000; 36(3 Supplement 1): 1117.
 
[7]  Harpaz D, Kriwisky M, Cohen AJ, Medalion B, Rozenman Y. Unusual form of cardiac rupture: Sealed subacute left ventricular free wall rupture, evolving to intramyocardial dissecting hematoma and to pseudoaneurysm formation— A case report and review of the literature. Journal of the American Society of Echocardiography. 2001; 14(3): 219-27.
 
[8]  Matteucci M, Fina D, Jiritano F, Blankesteijn WM, Raffa GM, Kowalewski M, et al. Sutured and sutureless repair of postinfarction left ventricular free-wall rupture: a systematic review. European Journal of Cardio-Thoracic Surgery. 2019; 56(5): 840-8.
 
[9]  Stolt V, Cook S, Raber L, Wani S, Garachamani A, Vogel R, et al. Amplatzer Septal Occluder to treat iatrogenic cardiac perforations. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2012; 79(2): 263-70.
 
[10]  Mullasari AS, Umesan CV, Krishnan U, Srinivasan S, Ravikumar M, Raghuraman H. Transcatheter closure of post–myocardial infarction ventricular septal defect with Amplatzer septal occluder. Catheterization and Cardiovascular Interventions. 2001; 54(4): 484-7.
 
[11]  Roth CP, Qarmali M, Litovsky SH, Brott BC. Myocardial rupture after small acute myocardial infarction in the absence of coronary artery disease. Cardiovascular Pathology. 2018; 37: 26-9.
 
[12]  Dar T, Yarlagadda B, Gunasekaran P, Lakkireddy D, Wiley MA. Successful Percutaneous Closure of Traumatic Right Ventricular Free Wall Rupture Using Amplatzer Vascular Plug Devices. J Atr Fibrillation. 2018; 11(2): 2095.
 
[13]  Vogel R, Windecker S, Meier B. Transcatheter repair of iatrogenic left ventricular free-wall perforation. Catheterization and Cardiovascular Interventions. 2006; 68(6): 829-31.
 
[14]  Gladding Patrick A, Ruygrok Peter N, Greaves Sally C, Gerber Ivor L, Hamer Andrew W. Percutaneous Closure of a Left Ventricular Free-Wall Rupture Site. Circulation. 2006; 113(18): e748-e9.
 
[15]  Chiam PTL, Schneider LM, Ruiz CE. Cardiac perforation during patent foramen ovale closure sealed with an amplatzer PFO occluder. J Invasive Cardiol. 2008; 20(12): 665-8.
 
[16]  Saxena A, Karmakar S, Narang R. Successful Percutaneous Device Closure of Right Ventricular Perforation During Pericardiocentesis. JACC: Cardiovascular Interventions. 2016; 9(22): e221.
 
[17]  Eshtehardi P, Garachemani A, Meier B. Percutaneous closure of a postinfarction ventricular septal defect and an iatrogenic left ventricular free-wall perforation using two Amplatzer muscular VSD occluders. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2009; 74(2): 243-6.
 
[18]  Stolt V, Cook S, Räber L, Wani S, Garachamani A, Vogel R, et al. Amplatzer septal occluder to treat iatrogenic cardiac perforations. Catheterization and Cardiovascular Interventions. 2012; 79(2): 263-70.
 
[19]  Elbey MA, Ertas G, Bacaksiz A, Goktekin O, Erdogan E. Transcatheter closure of left ventricular free wall rupture with Amplatzer atrial septal defect occluder. Clinical Research in Cardiology. 2013; 102(4): 313-4.
 
[20]  Acharya D, Nagaraj H, Misra VK. Transcatheter closure of left ventricular pseudoaneurysm. J Invasive Cardiol. 2012; 24(6): E111-4.
 
[21]  Vatan B, Akdemir R, Cakar M, Gunduz H, Varim C. Immediate Primary Transcatheter Closure of Left Ventricular Free Wall Rupture after Myocardial Infarction. Cardiology. 2013; 125(2): 82-5.
 
[22]  Meier B, Tarbine SG, Costantini CR. Percutaneous management of left atrial appendage perforation during device closure. Catheterization and Cardiovascular Interventions. 2014; 83(2): 305-7.
 
[23]  Tsai IC, Lin M-C, Jan S-L, Fu Y-C. Multidetector Row Computed Tomography for Percutaneous Closure of a Left Ventricular Free Wall Rupture After Myocardial Infarction. JACC: Cardiovascular Interventions. 2015; 8(11): e175-e6.
 
[24]  Mohamed E, Telila T, Osaki S, Jacobson K. Percutaneous closure of left ventricle pseudoaneurysm using 3D printed heart model for procedure planning: A novel approach. Catheterization and Cardiovascular Interventions. 2019; 94(6): 874-7.
 
[25]  Singleton MJ, Brunetti R, Schoenfeld MH, Bhave PD, Zhao DX, Whalen SP. Lead extraction complicated by right ventricular pseudoaneurysm: Percutaneous closure with septal occluder device. HeartRhythm Case Reports. 2019; 5(11): 542-4.
 
[26]  Holmes DR, Nishimura R, Fountain R, Turi ZG. Iatrogenic Pericardial Effusion and Tamponade in the Percutaneous Intracardiac Intervention Era. JACC: Cardiovascular Interventions. 2009; 2(8): 705-17.
 
[27]  Kariyanna PT, Jayarangaiah A, Pedalino R, Hegde S, Marmur JD, Shenoy A, et al. Esophago-pericardial Fistula Induced Community Acquired Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Cardiac Tamponade - A Rare Case Report and Literature Review. Am J Med Case Rep. 2018; 6(6): 109-13.
 
[28]  Pollak H, Diez W, Spiel R, Enenkel W, Mlczoch J. Early diagnosis of subacute free wall rupture complicating acute myocardial infarction. European heart journal. 1993; 14(5): 640-8.
 
[29]  Murata H, Masuo M, Yoshimoto H, Toyama J, Shimada M, Shimamura Y, et al. Oozing type cardiac rupture repaired with percutaneous injection of fibrin-glue into the pericardial space. Japanese circulation journal. 2000; 64(4): 312-5.
 
[30]  Joho S, Asanoi H, Sakabe M, Nakagawa K, Kameyama T, Hirai T, et al. Long-term usefulness of percutaneous intrapericardial fibrin-glue fixation therapy for oozing type of left ventricular free wall rupture. Circulation journal. 2002; 66(7): 705-6.
 
[31]  Terashima M, Fujiwara S, Yaginuma GY, Takizawa K, Kaneko U, Meguro T. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction. The American journal of cardiology. 2008; 101(4): 419-21.
 
[32]  Harrison W, Ruygrok PN, Greaves S, Wijesinghe N, Charleson H, Wade C, et al. Percutaneous Closure of Left Ventricular Free Wall Rupture with Associated False Aneurysm to Prevent Cardioembolic Stroke. Heart, Lung and Circulation. 2008; 17(3): 250-3.
 
[33]  Alshehri HZ, Momenah TS, AlBaradai A, Sallam A, Alassal MA, Lawand S. Successful percutaneous closure of post myocardial infarction left ventricular ruptured pseudoaneurysm after failed surgical repair. Journal of Cardiology Cases. 2014; 9(4): 154-7.